Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.
Clinical trial NCT03085225 · COMPLETED
Trial details
- NCT number
- NCT03085225
- Sponsor
- Institut Bergonié
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-05
- Primary completion
- 2020-11-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.